TD Cowen lowered the firm’s price target on Avantor (AVTR) to $27 from $28 and keeps a Buy rating on the shares. The firm said while results and guide were a bit mixed, on the whole they portray demand is improving growth accelerating with Bioprocess leading and management executing ahead of plan on cost out and free cash flow generation.
Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AVTR:
- Avantor price target lowered to $26 from $28 at Stifel
- Morgan Stanley trims Avantor price target, says selloff ‘appears overdone’
- Avantor price target lowered to $22 from $24.50 at Bernstein
- Balanced Outlook on Avantor: Hold Rating Amidst Segment Underperformance and Strong Expense Management
- Favorable Risk-Reward Profile and Organic Growth Drive Buy Rating for Avantor